Lexicon Pharmaceuticals (LXRX) Other Operating Expenses (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Other Operating Expenses of $108000.0 for Q1 2026, up 260.0% year-over-year from $30000.0 in Q1 2025, and down 46.27% quarter-over-quarter from $201000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Other Operating Expenses (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Other Operating Expenses for 17 consecutive years, with $108000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 260.0% year-over-year to $108000.0; the TTM figure through Mar 2026 stood at $352000.0 (down 42.76% YoY), while the FY2025 annual figure was $274000.0, down 55.52% from the prior year.
- Other Operating Expenses declined to $108000.0 in Q1 2026 per LXRX's latest filing, from $201000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $10.7 million in Q2 2022 and bottomed at $7000.0 in Q3 2023.
- Historically, Other Operating Expenses has averaged $1.4 million across 5 years, with a median of $70500.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Operating Expenses sank 99.93% — and 2024, when it jumped 1975.0%.
- Lexicon Pharmaceuticals' Other Operating Expenses stood at $10.7 million in 2022, then sank by 99.34% to $70000.0 in 2023, then soared by 397.14% to $348000.0 in 2024, then slumped by 42.24% to $201000.0 in 2025, then slumped by 46.27% to $108000.0 in 2026.
- Business Quant data shows LXRX's Other Operating Expenses at $108000.0 in Q1 2026, $201000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Jun 30, 2022 | 10.69 Mn |
| Mar 31, 2022 | 8.49 Mn |
| Dec 31, 2021 | 8.85 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Jun 30, 2021 | 7.94 Mn |
| Mar 31, 2021 | 8.26 Mn |
| Dec 31, 2020 | 6.43 Mn |